You've got to love the idea of IBM Watson. The super-computer using advanced AI to learn everything, faster and better than any human being could ever hope to do. The hope is it would help us solve some of our most pressing problems. One of IBM's (IBM) high-profile challenges was their desire to cure cancer. Unfortunately, it has not happened.

Nothing kills a bad idea faster than good advertising. Yet, the diffusion of information into a system can be essential--especially in medicine. So the balance between the kind of stuff that "sticks to the roof of your customer's brain" and valuable information can be tricky and even contradictory. For most of us, the introduction of Watson's skill set wasn't as a peer-reviewed paper published in a top academic journal--it was a guy name Ken Jennings and the popular TV game show Jeopardy. After a winning streak of 74 shows, Jennings took on IBM Watson and the rest is history.

IBM (NYSE: IBM) has announced that several new European clients have selected IBM Watson Internet of Things (IoT) technologies, the company said. New contracts signed with Spanish electricity grid operator Red Elà ctrica de Espaà a, Italian elderly care provider Cooperativa Sole, Dutch telecommunications operator Tele2 and Israeli manufacturer of smart air conditioning Electra Group are examples of IBM s commitment to transforming business and improving operations with the power of Artificial Intelligence (AI)-enabled, IBM Cloud-based Internet of Things (IoT) technologies. Red Elà ctrica de Espaà a (http://www.ree.es/en), the sole transmission agent and operator of the national electricity system in Spain has selected IBM Watson IoT technologies as part of its Intelligent Asset Management initiative project. Israel s manufacturer and distributor of consumer goods, is collaborating with IBM to create smart air conditioning solutions, which incorporate Watson IoT technology.

IBM's artificial intelligence software, Watson, isn't ready to replace your doctor just yet. Medical experts working with the tech giant on its Watson for Oncology system discovered that it made'often inaccurate' and'unsafe' treatment recommendations, according to internal documents reviewed by Stat News. However, no patients were reportedly harmed despite Watson's missteps. Medical experts working with IBMon its Watson for Oncology system discovered that it made'often inaccurate' and'unsafe' treatment recommendations, internal documents showed The documents were included in two presentations given in June and July 2017 by IBM Watson's former deputy health chief Andrew Norden. In one case, a 65-year-old patient was diagnosed with lung cancer and said he had developed severe bleeding.

Last year, studies presented at the American Society of Clinical Oncology's annual meeting showed that IBM Watson was pretty darn good at creating treatment plans for cancer patients. Turns out, however, that the AI is still far from perfect: according to internal documents reviewed by health-oriented news publication Stat, some medical experts working with IBM on its Watson for Oncology system found "multiple examples of unsafe and incorrect treatment recommendations." In one particular case, a 65-year-old man was diagnosed a drug that could lead to "severe or fatal hemorrhage" even though he was already suffering from severe bleeding. The report puts the blame on the IBM engineers and the Memorial Sloan Kettering (MSK) Cancer Center doctors who helped train the AI. They reportedly fed Watson hypothetical patients' data and treatment recommendations by MSK doctors instead of real patients' information.

IBM's Watson supercomputer gave unsafe recommendations for treating cancer patients, according to documents reviewed by Stat. The report is the latest sign that Watson, once hyped as the future of cancer research, has fallen far short of expectations. In 2012, doctors at Memorial Sloan Kettering Cancer Center partnered with IBM to train Watson to diagnose and treat patients. But according to IBM documents dated from last summer, the supercomputer has frequently given bad advice, like when it suggested a cancer patient with severe bleeding be given a drug that could cause the bleeding to worsen. "This product is a piece of s--," one doctor at Jupiter Hospital in Florida told IBM executives, according to the documents. "We bought it for marketing and with hopes that you would achieve the vision.

Internal company documents from IBM show that medical experts working with the company's Watson supercomputer found "multiple examples of unsafe and incorrect treatment recommendations" when using the software, according to a report from Stat News. Stat reviewed documents that were included in two presentations given in June and July 2017 by IBM Watson's former deputy health chief Andrew Norden. The documents were reportedly shared with IBM Watson Health management. According to Stat, those documents provided strong criticism of the Watson for Oncology system, and stated that the "often inaccurate" suggestions made by the product bring up "serious questions about the process for building content and the underlying technology." One example in the documents is the case of a 65-year-old man diagnosed with lung cancer, who also seemed to have severe bleeding.

The graph represents a network of 3,658 Twitter users whose tweets in the requested range contained "ibm watson", or who were replied to or mentioned in those tweets. The network was obtained from the NodeXL Graph Server on Monday, 23 July 2018 at 10:31 UTC. The requested start date was Monday, 23 July 2018 at 00:01 UTC and the maximum number of days (going backward) was 14. The maximum number of tweets collected was 5,000. The tweets in the network were tweeted over the 11-day, 2-hour, 17-minute period from Wednesday, 11 July 2018 at 11:44 UTC to Sunday, 22 July 2018 at 14:01 UTC.

IBM Watson Health will continue to collaborate with the U.S. Department of Veterans Affairs on the development of treatment regimens for veterans with cancer through next June. IBM Watson Health has announced an extension through June 2019 of its collaboration with the U.S. Department of Veterans Affairs (VA) to help treat veterans with cancer using artificial intelligence (AI). The partners use the Watson cognitive computing platform to inform the delivery of personalized treatment plans by the VA's oncologists. This requires researchers and clinicians to sequence patients' DNA to locate likely cancer-causing mutations and determine strategies to target those mutations. AI can help oncologists interpret genomic data faster and with less difficulty.

File photo - Attendees gather at an IBM Watson event in lower Manhattan, New York Jan. 9, 2014. Two years ago, oncologists with the US Department of Veterans Affairs started using IBM Watson artificial intelligence to identify targeted treatment options for cancer patients. Now, they will be able to continue that work for at least another year. The VA and IBM Watson Health today announced an extension of their partnership through at least June 2019. Working out of a precision oncology "hub" in Durham, N.C., a small group of VA oncologists and pathologists receive tumor samples from patients around the country.